Maplight Therapeutics, Inc. · NASDAQ:MPLT

Kreitzer Anatol received 6,020 Maplight Therapeutics, Inc. shares as an award (Form 4)

Traded Aug 17, 2026 · Filed Aug 19, 2026

On Aug 17, 2026, Kreitzer Anatol (Chief Discovery Officer) received 6,020 Maplight Therapeutics, Inc. shares as an award, leaving 180,926 shares. Filed Aug 19, 2026 (Form 4).

Awarded
6,020 shares
Holding after
180,926 shares
Trading plan
No
Role
Chief Discovery Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Voting Common StockAward6,020180,926Direct

Source

View original at SEC

Related